Clinical trial
Multicenter phase 2 trial of arq 197 for subjects with relapsed or refractory germ cell tumors
The primary objective is to determine the objective response rate (ORR) after 4 cycles of therapy with ARQ 197 in subjects with GCT.
| Category | Value |
|---|---|
| Study start date | 2010-03-17 |